Delayed
Berne S.E.
|
5-day change
|
1st Jan Change
|
- CHF
|
-.--%
|
|
-.--%
|
-.--%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
6,032
|
3,454
|
5,801
|
3,463
|
3,624
|
3,215
|
-
|
-
|
Enterprise Value (EV)
1 |
6,898
|
4,548
|
6,576
|
4,319
|
4,647
|
3,272
|
3,768
|
4,091
|
P/E ratio
|
14.6
x
|
13.6
x
|
28.3
x
|
-35.7
x
|
13.2
x
|
30.7
x
|
11.7
x
|
9.54
x
|
Yield
|
2.72%
|
3.09%
|
2.32%
|
4.1%
|
3.88%
|
4.43%
|
4.38%
|
4.66%
|
Capitalization / Revenue
|
1.43
x
|
0.83
x
|
1.48
x
|
0.88
x
|
0.86
x
|
0.84
x
|
0.83
x
|
0.83
x
|
EV / Revenue
|
1.64
x
|
1.09
x
|
1.68
x
|
1.1
x
|
1.11
x
|
0.84
x
|
0.97
x
|
1.05
x
|
EV / EBITDA
|
9.54
x
|
6.45
x
|
9.61
x
|
5.97
x
|
7.18
x
|
5.47
x
|
6
x
|
5.9
x
|
EV / FCF
|
-531
x
|
87.5
x
|
16.9
x
|
28.4
x
|
-186
x
|
23.6
x
|
15.5
x
|
23.5
x
|
FCF Yield
|
-0.19%
|
1.14%
|
5.9%
|
3.52%
|
-0.54%
|
4.24%
|
6.44%
|
4.25%
|
Price to Book
|
2.31
x
|
1.23
x
|
2.16
x
|
1.47
x
|
1.44
x
|
1.24
x
|
1.25
x
|
1.17
x
|
Nbr of stocks (in thousands)
|
1,91,973
|
1,92,093
|
1,92,522
|
1,84,333
|
1,82,716
|
1,82,883
|
-
|
-
|
Reference price
2 |
31.42
|
17.98
|
30.13
|
18.78
|
19.84
|
17.58
|
17.58
|
17.58
|
Announcement Date
|
30/05/19
|
11/06/20
|
27/05/21
|
26/05/22
|
25/05/23
|
23/05/24
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
4,214
|
4,170
|
3,922
|
3,940
|
4,201
|
3,904
|
3,882
|
3,882
|
EBITDA
1 |
723
|
705
|
684
|
724
|
647
|
598
|
628.1
|
693.5
|
EBIT
1 |
566
|
539
|
504
|
556
|
465
|
410
|
430
|
496.2
|
Operating Margin
|
13.43%
|
12.93%
|
12.85%
|
14.11%
|
11.07%
|
10.5%
|
11.08%
|
12.78%
|
Earnings before Tax (EBT)
1 |
488
|
305
|
238
|
195
|
344
|
164
|
343.8
|
420
|
Net income
1 |
413
|
255
|
205
|
-101
|
276
|
108
|
289.1
|
331.5
|
Net margin
|
9.8%
|
6.12%
|
5.23%
|
-2.56%
|
6.57%
|
2.77%
|
7.45%
|
8.54%
|
EPS
2 |
2.146
|
1.321
|
1.064
|
-0.5260
|
1.502
|
0.5830
|
1.504
|
1.843
|
Free Cash Flow
1 |
-13
|
52
|
388
|
152
|
-25
|
179.5
|
242.5
|
174
|
FCF margin
|
-0.31%
|
1.25%
|
9.89%
|
3.86%
|
-0.6%
|
4.36%
|
6.25%
|
4.48%
|
FCF Conversion (EBITDA)
|
-
|
7.38%
|
56.73%
|
20.99%
|
-
|
29.51%
|
38.61%
|
25.09%
|
FCF Conversion (Net income)
|
-
|
20.39%
|
189.27%
|
-
|
-
|
73.01%
|
83.89%
|
52.48%
|
Dividend per Share
2 |
0.8550
|
0.5562
|
0.7000
|
0.7700
|
0.7700
|
0.7796
|
0.7699
|
0.8189
|
Announcement Date
|
30/05/19
|
11/06/20
|
27/05/21
|
26/05/22
|
25/05/23
|
23/05/24
|
-
|
-
|
Fiscal Period: March |
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
2024 S1
|
---|
Net sales
1 |
2,124
|
2,046
|
1,679
|
2,243
|
4,293
|
4,293
|
1,938
|
2,002
|
2,045
|
2,156
|
1,967
|
EBITDA
|
350
|
355
|
235
|
449
|
-
|
-
|
389
|
335
|
309
|
338
|
273
|
EBIT
|
265
|
274
|
151
|
353
|
-
|
-
|
293
|
263
|
222
|
243
|
180
|
Operating Margin
|
12.48%
|
13.39%
|
8.99%
|
15.74%
|
-
|
-
|
15.12%
|
13.14%
|
10.86%
|
11.27%
|
9.15%
|
Earnings before Tax (EBT)
|
225
|
80
|
26
|
212
|
-
|
-
|
-9
|
204
|
188
|
156
|
82
|
Net income
|
176
|
79
|
24
|
181
|
-
|
-
|
-28
|
-73
|
160
|
116
|
63
|
Net margin
|
8.29%
|
3.86%
|
1.43%
|
8.07%
|
-
|
-
|
-1.44%
|
-3.65%
|
7.82%
|
5.38%
|
3.2%
|
EPS
|
0.9160
|
1.230
|
0.1230
|
0.9410
|
-
|
-
|
-0.1480
|
-0.3780
|
0.8710
|
0.6310
|
0.3460
|
Dividend per Share
|
-
|
0.3112
|
0.2000
|
0.5000
|
-
|
-
|
0.2200
|
-
|
0.2200
|
-
|
-
|
Announcement Date
|
21/11/19
|
11/06/20
|
19/11/20
|
27/05/21
|
24/08/21
|
24/11/21
|
24/11/21
|
26/05/22
|
23/11/22
|
25/05/23
|
22/11/23
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
866
|
1,094
|
775
|
856
|
1,023
|
1,020
|
553
|
876
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.198
x
|
1.552
x
|
1.133
x
|
1.182
x
|
1.581
x
|
1.676
x
|
0.8801
x
|
1.263
x
|
Free Cash Flow
1 |
-13
|
52
|
388
|
152
|
-25
|
180
|
243
|
174
|
ROE (net income / shareholders' equity)
|
16.6%
|
9.38%
|
12.7%
|
15.9%
|
11.1%
|
10.7%
|
11.5%
|
12.6%
|
ROA (Net income/ Total Assets)
|
7.98%
|
3.83%
|
2.71%
|
5.65%
|
4.03%
|
3.86%
|
8.72%
|
4.93%
|
Assets
1 |
5,176
|
6,654
|
7,553
|
-1,788
|
6,847
|
6,365
|
3,317
|
6,718
|
Book Value Per Share
2 |
13.60
|
14.70
|
13.90
|
12.70
|
13.80
|
14.20
|
14.10
|
15.00
|
Cash Flow per Share
2 |
1.740
|
3.110
|
3.990
|
3.150
|
1.580
|
2.590
|
2.560
|
3.060
|
Capex
1 |
301
|
443
|
381
|
453
|
316
|
347
|
354
|
336
|
Capex / Sales
|
7.14%
|
10.62%
|
9.71%
|
11.5%
|
7.52%
|
8.42%
|
9.12%
|
8.66%
|
Announcement Date
|
30/05/19
|
11/06/20
|
27/05/21
|
26/05/22
|
25/05/23
|
23/05/24
|
-
|
-
|
Last Close Price
17.58
GBP Average target price
20.08
GBP Spread / Average Target +14.20% Consensus |
1st Jan change
|
Capi.
|
---|
| +17.07% | 6.53TCr | | -0.29% | 4.91TCr | | +21.61% | 4.29TCr | | +26.72% | 2.73TCr | | +9.25% | 1.92TCr | | +9.75% | 1.66TCr | | -2.14% | 1.65TCr | | -15.01% | 1.45TCr | | -30.22% | 1.41TCr |
Other Specialty Chemicals
|